Table 1 Clinical data off all the participants.
Overall | Fazekas score 1 | Fazekas score 2 | Fazekas score 3 | F | P value | |
|---|---|---|---|---|---|---|
Male:Female | 36:40 | 18:18 | 6:13 | 12:9 | 0.2460 | |
Age | 65.09 ± 9.18 | 62.00 ± 8.47 | 66.89 ± 10.37 | 68.76 ± 7.69 | 4.47 | < 0.05 |
Years of education | 7.71 ± 3.79 | 8.67 ± 3.31 | 6.26 ± 3.45 | 7.38 ± 4.50 | 2.73 | 0.0719 |
Duration of hypertension | 7.78 ± 7.48 | 5.90 ± 7.06 | 6.89 ± 6.81 | 11.81 ± 7.53 | 4.74 | < 0.05 |
Duration of type 2 diabetes | 4.25 ± 6.84 | 3.03 ± 65.43 | 6.26 ± 9.64 | 4.52 ± 5.82 | 1.43 | 0.2456 |
BMI | 25.68 ± 3.34 | 25.55 ± 3.315 | 25.91 ± 3.26 | 25.68 ± 3.60 | 0.06 | 0.9451 |
SBP | 142.2 ± 15.68 | 138.5 ± 17.23 | 144.9 ± 12.00 | 145.9 ± 15.13 | 1.99 | 0.1446 |
DBP | 86.67 ± 11.57 | 87.37 ± 12.45 | 85.63 ± 11.03 | 86.43 ± 10.98 | 0.10 | 0.9074 |
HbaA1c | 6.511 ± 1.69 | 6.269 ± 1.54 | 6.868 ± 1.71 | 6.590 ± 1.936 | 0.78 | 0.4601 |
TG | 1.462 ± 0.92 | 1.302 ± 0.79 | 1.593 ± 1.13 | 1.610 ± 0.9264 | 0.35 | 0.3538 |
LDL | 2.676 ± 0.90 | 2.613 ± 0.87 | 2.586 ± 1.03 | 2.863 ± 0.8445 | 0.57 | 0.5688 |
BUN | 4.745 ± 1.41 | 4.480 ± 0.90 | 4.768 ± 1.93 | 5.167 ± 1.543 | 1.66 | 0.1968 |
Scr | 63.02 ± 16.28 | 61.38 ± 15.42 | 59.13 ± 16.46 | 70.09 ± 16.20 | 2.96 | 0.0582 |
Albumin | 41.03 ± 3.77 | 42.01 ± 3.88 | 40.56 ± 2.62 | 39.89 ± 4.125 | 2.52 | 0.0874 |
LVWT | 8.769 ± 1.07 | 8.560 ± 1.05 | 8.837 ± 1.05 | 9.033 ± 1.037 | 1.55 | 0.2195 |